256 related articles for article (PubMed ID: 10482176)
1. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion.
Buerke M; Rupprecht HJ; vom Dahl J; Terres W; Seyfarth M; Schultheiss HP; Richardt G; Sheehan FH; Drexler H
Am J Cardiol; 1999 May; 83(10A):19G-22G. PubMed ID: 10482176
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA.
Rupprecht HJ; vom Dahl J; Terres W; Seyfarth KM; Richardt G; Schultheibeta HP; Buerke M; Sheehan FH; Drexler H
Circulation; 2000 Jun; 101(25):2902-8. PubMed ID: 10869261
[TBL] [Abstract][Full Text] [Related]
3. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
Avkiran M
Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
[TBL] [Abstract][Full Text] [Related]
4. GUARD During Ischemia Against Necrosis (GUARDIAN) trial in acute coronary syndromes.
Erhardt LR
Am J Cardiol; 1999 May; 83(10A):23G-25G. PubMed ID: 10482177
[TBL] [Abstract][Full Text] [Related]
5. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial.
Zeymer U; Suryapranata H; Monassier JP; Opolski G; Davies J; Rasmanis G; Linssen G; Tebbe U; Schröder R; Tiemann R; Machnig T; Neuhaus KL;
J Am Coll Cardiol; 2001 Nov; 38(6):1644-50. PubMed ID: 11704395
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury.
Aihara K; Hisa H; Sato T; Yoneyama F; Sasamori J; Yamaguchi F; Yoneyama S; Mizuno Y; Takahashi A; Nagai A; Kimura T; Kogi K; Satoh S
Eur J Pharmacol; 2000 Sep; 404(1-2):221-9. PubMed ID: 10980282
[TBL] [Abstract][Full Text] [Related]
7. Direct inhibition of the sodium/hydrogen exchanger after prolonged regional ischemia improves contractility on reperfusion independent of myocardial viability.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; Spinale FG
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1489-97. PubMed ID: 14666024
[TBL] [Abstract][Full Text] [Related]
8. A symposium: sodium-hydrogen exchange inhibition. Introduction.
Théroux P
Am J Cardiol; 1999 May; 83(10A):1G-2G. PubMed ID: 10482173
[No Abstract] [Full Text] [Related]
9. Na(+)/H(+)-exchange inhibition and aprotinin administration: promising tools for myocardial protection during minimally invasive CABG.
Hendrikx M; Rega F; Jamaer L; Valkenborgh T; Gutermann H; Mees U
Eur J Cardiothorac Surg; 2001 May; 19(5):633-9. PubMed ID: 11343944
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals.
Menown IB; Adgey AA
J Am Coll Cardiol; 2001 Nov; 38(6):1651-3. PubMed ID: 11704376
[No Abstract] [Full Text] [Related]
11. Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642).
Linz W; Albus U; Crause P; Jung W; Weichert A; Schölkens BA; Scholz W
Clin Exp Hypertens; 1998 Oct; 20(7):733-49. PubMed ID: 9764718
[TBL] [Abstract][Full Text] [Related]
12. Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model.
Kupatt C; Hinkel R; Horstkotte J; Deiss M; von Brühl ML; Bilzer M; Boekstegers P
Cardiovasc Res; 2004 Feb; 61(3):530-7. PubMed ID: 14962483
[TBL] [Abstract][Full Text] [Related]
13. Protection of the myocardial cell during ischemia.
Théroux P
Am J Cardiol; 1999 May; 83(10A):3G-9G. PubMed ID: 10482174
[TBL] [Abstract][Full Text] [Related]
14. Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na(+)-H+ exchange.
Garcia-Dorado D; González MA; Barrabés JA; Ruiz-Meana M; Solares J; Lidon RM; Blanco J; Puigfel Y; Piper HM; Soler-Soler J
Cardiovasc Res; 1997 Jul; 35(1):80-9. PubMed ID: 9302350
[TBL] [Abstract][Full Text] [Related]
15. A review of the GUARDIAN trial results: clinical implications and the significance of elevated perioperative CK-MB on 6-month survival.
Chaitman BR
J Card Surg; 2003; 18 Suppl 1():13-20. PubMed ID: 12691375
[TBL] [Abstract][Full Text] [Related]
16. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study.
Boyce SW; Bartels C; Bolli R; Chaitman B; Chen JC; Chi E; Jessel A; Kereiakes D; Knight J; Thulin L; Theroux P;
J Thorac Cardiovasc Surg; 2003 Aug; 126(2):420-7. PubMed ID: 12928639
[TBL] [Abstract][Full Text] [Related]
17. Na(+)/H(+) exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion.
Strömer H; de Groot MC; Horn M; Faul C; Leupold A; Morgan JP; Scholz W; Neubauer S
Circulation; 2000 Jun; 101(23):2749-55. PubMed ID: 10851214
[TBL] [Abstract][Full Text] [Related]
18. Myocardial protection by Na(+)-H+ exchange inhibition in ischemic, reperfused porcine hearts.
Klein HH; Pich S; Bohle RM; Wollenweber J; Nebendahl K
Circulation; 1995 Aug; 92(4):912-7. PubMed ID: 7641374
[TBL] [Abstract][Full Text] [Related]
19. A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide).
Chakrabarti S; Hoque AN; Karmazyn M
J Mol Cell Cardiol; 1997 Nov; 29(11):3169-74. PubMed ID: 9405190
[TBL] [Abstract][Full Text] [Related]
20. [Na+/H+ exchange inhibitors for ischemic diseases].
Hashimoto K
Nihon Yakurigaku Zasshi; 2001 Dec; 118(6):363-70. PubMed ID: 11778453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
